Objective To observe the effect of TongFengNing Decoction （TD） on uric acid levels, xanthine oxidase （XOD） activity, and XOD mRNA expression of hyperuricemia （HUA） model rats. Methods： 90 rats were randomly ...Objective To observe the effect of TongFengNing Decoction （TD） on uric acid levels, xanthine oxidase （XOD） activity, and XOD mRNA expression of hyperuricemia （HUA） model rats. Methods： 90 rats were randomly divided into 6 groups （n=15）, and the HUA model in all groups except the blank group was established by administering hypoxanthine （HX） by gavage and injecting potassium oxonate （OAPS） intraperitoneally. Rats in all TD groups and allopurinol group were administered multiple doses of TD and a single dose of allopurinol by gavage twice daily for 21 days, while the blank group and the model group were administered normal saline. On the 7th, 14th, and 21st days of drug intervention, serum uric acid （SUA）, urine uric acid （UUA）, intestinal uric acid （IUA）, as well as XOD activity and mRNA expression in the liver and small intestine were measured in randomly selected 5 rats of each group. Results： On the 14th and 21st days of intervention, all TD dose groups and the allopurinol group showed decreased SUA and IUA levels, increased UUA levels, as well as decreased XOD activity and mRNA expression in the liver and small intestine, compared with the model group （P 〈 0.05）. The low- and high-dose TD group and the allopurinol group showed increased SUA and IUA levels, as well as XOD activity and mRNA expression in the liver and small intestine, and decreased UUA levels, compared with the moderate-dose TD group （P〈0.05）. Upon extending the drug intervention time of each TD dose group, SUA and IUA levels, XOD activity, and XOD mRNA expression in the liver and small intestine decreased and UUA levels increased （P 〈 0.05）. Conclusion： TD reduces SUA levels in HUA model rats, which promotes uric acid excretion and inhibits XOD activity and XOD mRNA expression to reduce uric acid production. The reduction in uric acid level by the intermediate dose of TD was better than that by allopurinol and the low and high doses of TD.展开更多
Objective： To observe the clinical effect of electroacupuncture（EA） plus self-made Jiawei Jinhuanggao（Supplemented Golden Yellow Paste） for gouty arthritis. Methods： A total of 80 cases with gouty arthritis were...Objective： To observe the clinical effect of electroacupuncture（EA） plus self-made Jiawei Jinhuanggao（Supplemented Golden Yellow Paste） for gouty arthritis. Methods： A total of 80 cases with gouty arthritis were randomly allocated into an observation group（n=40） and a Western medication group（n=40）. Cases in the observation group received EA and external application of self-made Jiawei Jinhuanggao（Supplemented Golden Yellow Paste）, whereas cases in the Western medication group took Colchicine and Allopurinol tablets orally. After 10 d of treatment, the pain, joint swelling and uric acid in blood were observed. In addition, the follow-up was conducted 6 months after end of the treatment to evaluate the long-term effect. Results： After treatment, there were no between-group statistical differences in pain and uric acid in blood（P〈0.05）; and there were between-group statistical differences in joint swelling and relapse rate（P〈0.05）. The total effective rate was 97.5% in the observation group, versus 95.0% in the Western medication group, showing no statistical difference（P〈0.05）. Conclusion： EA plus Jiawei Jinhuanggao（Supplemented Golden Yellow Paste） has safe and long-term efficacy for gouty arthritis efficacy.展开更多
文摘Objective To observe the effect of TongFengNing Decoction （TD） on uric acid levels, xanthine oxidase （XOD） activity, and XOD mRNA expression of hyperuricemia （HUA） model rats. Methods： 90 rats were randomly divided into 6 groups （n=15）, and the HUA model in all groups except the blank group was established by administering hypoxanthine （HX） by gavage and injecting potassium oxonate （OAPS） intraperitoneally. Rats in all TD groups and allopurinol group were administered multiple doses of TD and a single dose of allopurinol by gavage twice daily for 21 days, while the blank group and the model group were administered normal saline. On the 7th, 14th, and 21st days of drug intervention, serum uric acid （SUA）, urine uric acid （UUA）, intestinal uric acid （IUA）, as well as XOD activity and mRNA expression in the liver and small intestine were measured in randomly selected 5 rats of each group. Results： On the 14th and 21st days of intervention, all TD dose groups and the allopurinol group showed decreased SUA and IUA levels, increased UUA levels, as well as decreased XOD activity and mRNA expression in the liver and small intestine, compared with the model group （P 〈 0.05）. The low- and high-dose TD group and the allopurinol group showed increased SUA and IUA levels, as well as XOD activity and mRNA expression in the liver and small intestine, and decreased UUA levels, compared with the moderate-dose TD group （P〈0.05）. Upon extending the drug intervention time of each TD dose group, SUA and IUA levels, XOD activity, and XOD mRNA expression in the liver and small intestine decreased and UUA levels increased （P 〈 0.05）. Conclusion： TD reduces SUA levels in HUA model rats, which promotes uric acid excretion and inhibits XOD activity and XOD mRNA expression to reduce uric acid production. The reduction in uric acid level by the intermediate dose of TD was better than that by allopurinol and the low and high doses of TD.
文摘Objective： To observe the clinical effect of electroacupuncture（EA） plus self-made Jiawei Jinhuanggao（Supplemented Golden Yellow Paste） for gouty arthritis. Methods： A total of 80 cases with gouty arthritis were randomly allocated into an observation group（n=40） and a Western medication group（n=40）. Cases in the observation group received EA and external application of self-made Jiawei Jinhuanggao（Supplemented Golden Yellow Paste）, whereas cases in the Western medication group took Colchicine and Allopurinol tablets orally. After 10 d of treatment, the pain, joint swelling and uric acid in blood were observed. In addition, the follow-up was conducted 6 months after end of the treatment to evaluate the long-term effect. Results： After treatment, there were no between-group statistical differences in pain and uric acid in blood（P〈0.05）; and there were between-group statistical differences in joint swelling and relapse rate（P〈0.05）. The total effective rate was 97.5% in the observation group, versus 95.0% in the Western medication group, showing no statistical difference（P〈0.05）. Conclusion： EA plus Jiawei Jinhuanggao（Supplemented Golden Yellow Paste） has safe and long-term efficacy for gouty arthritis efficacy.
